# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Last week, these 10 large-cap stocks had the worst performance. NICE, PBR, FIX, LI, MLM, VMC, BMRN, EDU, GFI, MUFG all saw sign...
Baird analyst Joel Beatty downgrades Biomarin Pharmaceutical (NASDAQ:BMRN) from Outperform to Neutral and lowers the price t...
-SEC Filing
Evercore ISI Group analyst Cory Kasimov initiates coverage on Biomarin Pharmaceutical (NASDAQ:BMRN) with a Outperform rating...